Take the chance to meet and discuss with leading investors and potential partners!
SwedenBIO annually organizes this event where investors, companies and decision makers in Life Science can meet and interact. The objective for the day is to showcase a selection of interesting business cases and partnering opportunities!
The possibility to pre-schedule strategic 1-on-1 meetings now open!
Main Sponsor:
Confirmed Investors:
Apposite Capital LLP, Yorkville Advisors, Sunstone Capital, HealthCap, Omega Fund Management UK, Accelerator Nordic AB, SEB Venture Capital, SLS Invest, Innovationsbron, Life Equity Group, Novo A/S, InnovationsKapital, MedImmune Ventures, ALMI Invest, Industrifonden, LinkMed
Confirmed Companies:
AstraZeneca, Medivir, Swedish Orphan Biovitrum, Olink Genomics, Aprea AB, GE Healthcare, Affibody, Dermagen, Abbott, Oxypharma, Sento Clone, Xbrane Bioscience, Hansa Medical, Biotage, Teva Pharmaceuticals, Airsonett, Gyros, Adenovir Pharma, Axcentua, NeuroNova, Photocure, Vironova, Biotie, Dilafor, Moberg Derma, Creative Antibiotics Sweden AB, NovoSAID, Oncopeptides, Athera Biotechnologies, Nuevolution, CellaVision, Medfield Diagnostics AB, Bactiguard, Karo Bio
Time: March 22nd, 2010, 08.00-18.30
Place: Clarion Hotel Sign, Stockholm
To programme and registration
SwedenBIOs Annual events
 |
 |
|
|
|
|
|
|
For more information click on the banner! |
|
|
Check out the SwedenBIO activities for the year in the Agenda 2010.